What is Arrayjet?
Arrayjet is a leader in microarray technology, renowned for offering the fastest microarray printers and comprehensive custom microarray services. Leveraging patented inkjet technology, the company delivers high-throughput, flexible, and cost-effective solutions for the creation of protein, antibody, oligo, and DNA microarrays, as well as multiplex diagnostics. Serving the research and healthcare sectors, Arrayjet prioritizes collaborative, long-term relationships to achieve scientific and commercial objectives. The company's commitment to quality is validated by its ISO 13485:2016 certification, operating from its facility in Scotland, UK.
How much funding has Arrayjet raised?
Arrayjet has raised a total of $868K across 1 funding round:
Unspecified
$868K
Unspecified (2016): $868K with participation from Scottish Enterprise and Archangel Investors
Key Investors in Arrayjet
Scottish Enterprise
Scottish Enterprise is a national economic development agency of the Scottish Government, focused on driving economic growth and innovation within Scotland.
Archangel Investors
Archangel Investors is an investment group that provides backing to promising companies, likely focusing on early-stage and growth-stage ventures with strong market potential.
What's next for Arrayjet?
The recent major strategic investment signals a new phase of growth and development for Arrayjet. This capital infusion is expected to accelerate the company's innovation in microarray printing and custom services, potentially expanding its reach into new diagnostic and drug discovery markets. Arrayjet's focus on high-throughput solutions positions it to capitalize on the increasing demand for advanced life science tools, further solidifying its market leadership and contributing to advancements in personalized medicine and disease research.
See full Arrayjet company page
